These findings highlight the distinct patterns of PSMB9 genetic alterations across different tumor types, with a marked predominance of deep deletion in mature B-cell neoplasms contrasting with the prevalence of amplification in most other malignancies. The gene discussed is PSMB9; the disease is neoplasm.